Johnson Lloyd E.'s Insider Trades & SAST Disclosures
Johnson Lloyd E.'s most recent trade in Beazer Homes USA Inc. was a trade of 22,500 Common Stock done at an average price of $22.2 . Disclosure was reported to the exchange on Feb. 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Johnson Lloyd E..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beazer Homes USA Inc. | Lloyd E. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 22.23 per share. | 10 Feb 2025 | 22,500 | 45,000 (0%) | 0% | 22.2 | 500,236 | Common Stock |
| Beazer Homes USA Inc. | Lloyd E. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 22.68 per share. | 07 Feb 2025 | 22,500 | 22,500 (0%) | 0% | 22.7 | 510,379 | Common Stock |
| VSE Corp. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 1,454 | 6,706 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 2,811 | 18,531 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2024 | 2,811 | 4,531 (0%) | 0% | - | Common Stock | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 75 | 21,342 | - | - | Deferred Restricted Stock Units | |
| Beazer Homes USA Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2024 | 5,051 | 34,630 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,207 | 10,240 (0%) | 0% | - | Common Stock | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 1,893 | 21,115 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Sale of securities on an exchange or to another person at price $ 63.13 per share. | 02 May 2024 | 24,000 | 260 (0%) | 0% | 63.1 | 1,515,120 | Common Stock |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 81 | 19,222 | - | - | Deferred Restricted Stock Units | |
| VSE Corp. | Lloyd Johnson E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 1,737 | 5,252 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| Apogee Enterprises Inc. | Johnson Lloyd E. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 83 | 19,141 | - | - | Deferred Restricted Stock Units | |
| Beazer Homes USA Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 6,024 | 29,579 (0%) | 0% | 0 | Common Stock | |
| Haemonetics Corp. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 2,226 | 8,033 (0%) | 0% | - | Common Stock | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 83 | 18,960 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 2,409 | 18,877 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 91 | 16,468 | - | - | Deferred Restricted Stock Units | |
| VSE Corp. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 2,146 | 3,515 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 81 | 16,377 | - | - | Deferred Restricted Stock Units | |
| Beazer Homes USA Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 14,181 | 23,555 (0%) | 0% | 0 | Common Stock | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 93 | 16,296 | - | - | Deferred Restricted Stock Units | |
| Haemonetics Corp. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,730 | 5,807 (0%) | 0% | - | Common Stock | |
| VSE Corp. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2022 | 1,369 | 1,369 (0%) | 0% | 0 | Common Stock, par value $.05 | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 74 | 16,203 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 2,773 | 16,129 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 62 | 13,356 | - | - | Deferred Restricted Stock Units | |
| Beazer Homes USA Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 7,679 | 9,374 (0%) | 0% | 0 | Common Stock | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 68 | 13,239 | - | - | Deferred Restricted Stock Units | |
| Haemonetics Corp. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 3,077 | 3,077 (0%) | 0% | - | Common Stock | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 51 | 13,171 | - | - | Deferred Restricted Stock Units | |
| Beazer Homes USA Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2021 | 1,695 | 1,695 (0%) | 0% | 0 | Common Stock | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 2,721 | 2,721 | - | - | Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 50 | 10,399 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2020 | 60 | 10,348 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 89 | 10,287 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 42 | 10,198 | - | - | Deferred Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2020 | 4,920 | 4,920 | - | - | Restricted Stock Units | |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 18.75 per share. | 14 Apr 2020 | 24,000 | 24,000 (0%) | 0% | 18.7 | 449,974 | Common Stock |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 18.75 per share. | 14 Apr 2020 | 22,540 | 22,540 (0%) | 0% | 18.7 | 422,600 | Common Stock |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 18.73 per share. | 14 Apr 2020 | 2,600 | 2,600 (0%) | 0% | 18.7 | 48,706 | Common Stock |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Purchase of securities on an exchange or from another person at price $ 18.73 per share. | 14 Apr 2020 | 2,600 | 2,600 (0%) | 0% | 18.7 | 48,706 | Common Stock |
| Apogee Enterprises Inc. | Lloyd E. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2020 | 18 | 2,024 | - | - | Deferred Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges